| Literature DB >> 32355878 |
Marie-Anne Guillaumot1, Maximilien Barret1, Jérémie Jacques2, Romain Legros2, Mathieu Pioche3, Jérome Rivory3, Gabriel Rahmi4, Vincent Lepilliez5, Edouard Chabrun6, Sarah Leblanc1, Stanislas Chaussade1.
Abstract
Background and study aims Endoscopic full-thickness resection allows resection of early gastrointestinal neoplasms not amenable to conventional endoscopic resection techniques, due to their location, presence of submucosal fibrosis, or suspected deep mural invasion. It is typically achieved using a dedicated over-the-scope device (full-thickness resection device or FTRD). The aim of our study was to evaluate the feasibility, safety, and clinical outcomes of endoscopic full-thickness resection using an endoscopic submucosal dissection (ESD) knife. Patients and methods Consecutive patients who underwent full-thickness endoscopic resection at six tertiary care centers from August 2010 to June 2017 were retrospectively included. We conducted a comparative analysis of patient characteristics, technical success, adverse events, and time to discharge between patients treated by a full-thickness resection using an ESD knife. Results Twenty-one procedures were performed using an ESD knife. En-bloc resection and R0 resection rates were 95.2 % and 65 %, respectively. Clinical symptoms of perforation occurred in 66.7 %. There was no need for surgery or additional endoscopic procedures. Conclusion Endoscopic full-thickness resection of early colorectal neoplasms using an ESD knife might be feasible and safe. It allows complete resection of lesions with no limitation in size. The technique may be preferable to an other-the-scope resection device in lesions larger than 20 mm, and to surgery in selected cases of low-risk T1 colorectal carcinomas, non-lifting adenomas, submucosal tumors, or technically challenging lesion locations.Entities:
Year: 2020 PMID: 32355878 PMCID: PMC7164998 DOI: 10.1055/a-1127-3092
Source DB: PubMed Journal: Endosc Int Open ISSN: 2196-9736
Fig. 1 aEndoscopic full-thickness (transparietal) resection procedure. A Paris 0-Is + IIc lesion of the lower rectum was marked with an endoscopic submucosal dissection knife and the submucosal layer was injected (Panel 1A). b Mucosal incision was achieved and c submucosal dissection performed until reaching the muscularis propria. d Transparietal dissection was achieved, allowing en bloc resection of a T2 adenocarcinoma. e The resection bed was finally closed with clips.
Baseline characteristics of 21 neoplastic colorectal lesions in 21 patients treated by endoscopic full-thickness resection using an ESD knife.
| n = 21 | |
| Age – mean ± SD (range), years | 65.6 ±10.5 (38–85) |
| Male/female ratio | 11/10 |
| Anticoagulant/Antithrombotic use – n | 2/3 |
| Prior therapeutics – n (%) | 11 (52) |
| Location – n | |
Appendix/cecum/right/transverse/left/ | 0/0/2/0/0/3/16 |
sigmoid/rectum | |
Colon vs. rectum | 5 (23.8) vs. 16 (76.2) |
| Indication for resection – n (%) | |
Failed prior resection attempt | 15 (71.4) |
Invasive pattern | 4 (19) |
Submucosal lesion | 2 (9.5) |
Intra diverticular lesion or appendicular lesion | 0 |
| Size – Mean ± SD size (range), mm | 46.2 ± 2.1 (10–95) |
| Paris classification subtype – n | |
| Is/ IIa/Is + IIa/IIa + IIb/IIa + IIc/IIb/IIc/ Is + IIc/Subepithelial tumor | 3/3/5/0/3/0/3/3/1 |
ESD, endoscopic submucosal dissection; SD, standard deviation
Therapeutic outcomes after full-thickness resection of 21 early colorectal neoplasms using an ESD knife.
| n = 21 | |
| Successful resection rate – n (%) | 21 (100) |
| En bloc resection rate – n (%) | 19 (95.2) |
| R0 resection rate – n (%) | 13 (65) |
| Curative resection rate for carcinoma – n (%) | 2 (15.4) |
| Surgery for cancer – n (%) | 5 (38.4) |
| Admission time – Mean ± SD, (range), days | 3.1 ± 1.95 (1–8) |
| Complications – n (%) | |
Clinical perforation | 14 (66.7)14 (66.7) |
Per-endoscopic desufflation/medical/surgical treatment | 2/12/0 |
Delayed bleeding | 0 (0) |
ESD, endoscopic submucosal dissection
Histopathologic findings in 21 neoplastic colorectal lesions managed by full-thickness resection using an ESD knife.
| n = 21 | |
| Adenoma – n (%) | 6 (28.6) |
| Cancer – n (%) | 13 (62) |
| Tumor infiltration – n (%) | |
Tis | 2 (9.5) |
T1 superficial
| 1 (4.8) |
T1 deep
| 4 (19) |
T2 | 5 (23.8) |
T3 | 1 (4.8) |
| Lymphovascular involvement – n (%) | 4 (30.7) |
| Undifferentiated adenocarcinoma – n (%) | 1 (7.6) |
| GIST/NET – n (%) | 1 (7.6) |
| Absence of neoplasia – n (%) | 1 (7.6) |
ESD, endoscopic submucosal dissection; GIST/NET, gastrointestinal stromal tumor/neuroendocrine tumor
Superficial submucosal infiltration < 1000 micrometers
Deep submucosal infiltration > 1000 micrometers